BioCentury
ARTICLE | Clinical News

Auryxia regulatory update

August 24, 2015 7:00 AM UTC

EMA’s CHMP recommended approval of Fexeric ferric citrate from Keryx to treat hyperphosphatemia in adults with chronic kidney disease (CKD). Keryx markets the oral ferric iron-based phosphate binder a...